Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Curigliano, G.
490  Ergebnisse:
Personensuche X
?
1

Prognostic value of HER2DX in early-stage HER2-positive bre..:

Villacampa, G. ; Pascual, T. ; Brasó-Maristany, F....
ESMO Open.  9 (2024)  3 - p. 102388 , 2024
Link: https://doi.org/10.1016/..
 
?
2

52P Comparing the genomic landscape of de novo vs recurrent..:

Giugliano, F. ; Douglas, J.R. Dixon ; Dien, A. Tran...
ESMO Open.  9 (2024)  - p. 103059 , 2024
Link: https://doi.org/10.1016/..
 
?
3

257P A low fT3/fT4 ratio as a negative prognostic factor in..:

Scafetta, R. ; Loupakis, F. ; Marsicano, R.M....
ESMO Open.  9 (2024)  - p. 103278 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Clinically locally advanced breast cancers: the EUSOMA expe..:

Van Dam, P. ; Tomatis, M. ; Ponti, A....
European Journal of Cancer.  200 (2024)  - p. 113711 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Pan-Asian adapted ESMO Clinical Practice Guidelines for the..:

Shitara, K. ; Fleitas, T. ; Kawakami, H....
ESMO Open.  9 (2024)  2 - p. 102226 , 2024
Link: https://doi.org/10.1016/..
 
?
6

98P Cancers of unknown primary (CUP): Real-world clinical o..:

Bielo, L. Boscolo ; Belli, C. ; Crimini, E....
ESMO Open.  9 (2024)  - p. 102324 , 2024
Link: https://doi.org/10.1016/..
 
?
7

261TiP TROPION-Breast05: Phase (Ph) III study of datopotama..:

Schmid, P. ; Oliveira, M. ; O'Shaughnessy, J....
ESMO Open.  9 (2024)  - p. 103282 , 2024
Link: https://doi.org/10.1016/..
 
?
8

26O Phase I dose-escalation trial with tumor-targeted inter..:

Curigliano, G. ; Belli, C. ; Colombo, I....
ESMO Open.  9 (2024)  - p. 102354 , 2024
Link: https://doi.org/10.1016/..
 
?
9

246P Clinical utility of molecular tumor board in metastati..:

Marra, A. ; Bielo, L. Boscolo ; Crimini, E....
ESMO Open.  9 (2024)  - p. 103267 , 2024
Link: https://doi.org/10.1016/..
 
?
10

Trastuzumab deruxtecan versus trastuzumab emtansine in HER2..:

Hurvitz, S.A. ; Kim, S.-B. ; Chung, W.-P....
ESMO Open.  9 (2024)  5 - p. 102924 , 2024
Link: https://doi.org/10.1016/..
 
?
11

Expanding Horizons in Oncology: A Vision for ESMO Open:

Curigliano, G.
ESMO Open.  9 (2024)  1 - p. 102242 , 2024
Link: https://doi.org/10.1016/..
 
?
12

152P Inflammatory breast cancer (IBC) in low and middle-inc..:

Schlam, I.M. ; Hirko, K. ; Gerson, D. Shveid...
ESMO Open.  9 (2024)  - p. 103139 , 2024
Link: https://doi.org/10.1016/..
 
?
13

132P Clinico-pathological characteristics, treatments and s..:

Giugliano, F. ; Bertaut, A. ; Blanc, J....
ESMO Open.  9 (2024)  - p. 103119 , 2024
Link: https://doi.org/10.1016/..
 
?
14

91P Prevalence of HR-/DDR-genes alterations across sarcoma ..:

Bielo, L. Boscolo ; Repetto, M. ; Crimini, E....
ESMO Open.  9 (2024)  - p. 102317 , 2024
Link: https://doi.org/10.1016/..
 
?
15

101P Primary malignant phyllodes tumors of the breast: A re..:

Valenza, C. ; De Pas, T.M. ; Gaeta, A....
ESMO Open.  9 (2024)  - p. 102490 , 2024
Link: https://doi.org/10.1016/..
 
1-15